“∞ωωω˛ YEOTOP4 COM ∞ ┎글로벌┚수진동OPぐ수진동오피✥수진동키스방お수진동마사지ⅱ수진동건마☃수진동안마■수진동스파”的搜索结果，显示 131-140 项，共有 4395 项

1. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

2. 神经科- 临床试验- 妙佑医疗国际

   This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data, brain imaging ...

3. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating ...

4. 神经科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. The purpose of this Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial study is to assess post ...

5. 放射科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to to determine the impact of anesthesia (liposomal bupivacaine) on diaphragm muscle forces using a non-invasive ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study to Develop Liquid Biopsy for ...

7. 神经科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. The purpose of this Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial study is to assess post ...

8. 神经科- 临床试验- 妙佑医疗国际

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. Cerebrospinal Fluid (CSF) Biomarkers for Prediction of Dementia.

10. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

    2. Olmsted County residents at the time of study entry. Exclusion criteria: 1. Pediatric population (age<18). 2. Unwilling to participate or unable to consent.